Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company

HOSE:DBD Stok Raporu

Piyasa değeri: ₫4.6t

Binh Dinh Pharmaceutical and Medical Equipment Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 4/6

Binh Dinh Pharmaceutical and Medical Equipment has been growing earnings at an average annual rate of 14.9%, while the Pharmaceuticals industry saw earnings growing at 8.3% annually. Revenues have been growing at an average rate of 6.8% per year. Binh Dinh Pharmaceutical and Medical Equipment's return on equity is 16.7%, and it has net margins of 15%.

Anahtar bilgiler

14.9%

Kazanç büyüme oranı

15.0%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi13.0%
Gelir büyüme oranı6.8%
Özkaynak getirisi16.7%
Net Marj15.0%
Son Kazanç Güncellemesi30 Sep 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Gelir ve Gider Dağılımı

Binh Dinh Pharmaceutical and Medical Equipment nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

HOSE:DBD Gelir, gider ve kazançlar (VND Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Sep 241,694,143254,652516,5170
30 Jun 241,672,702227,311509,7440
31 Mar 241,653,745230,100505,4480
31 Dec 231,651,770231,387501,5380
30 Sep 231,672,357236,045504,2270
30 Jun 231,654,996222,828509,3870
31 Mar 231,577,853226,700494,7210
31 Dec 221,554,821209,457494,3120
30 Sep 221,494,595192,082457,4060
30 Jun 221,654,406179,227465,7400
31 Mar 221,628,301175,687443,7700
31 Dec 211,558,504162,646405,4370
30 Sep 211,500,950144,547377,4390
30 Jun 211,224,917151,994319,0570
31 Mar 211,165,758136,014284,7550
31 Dec 201,256,952138,916309,3560
30 Sep 201,310,512152,680303,5940
30 Jun 201,341,568136,409295,3660
31 Mar 201,389,839134,560314,7760
31 Dec 191,261,729128,005254,0460
30 Sep 191,251,065124,796236,9740
30 Jun 191,309,152137,586215,6400
31 Mar 191,304,700140,059210,7340
31 Dec 181,401,024146,704241,5710
30 Sep 181,400,268155,163253,2300
30 Jun 181,382,479153,894277,0450
31 Mar 181,393,974147,133293,7980
31 Dec 171,388,227147,952303,7340
30 Sep 171,383,637144,064314,2360
30 Jun 171,383,273132,605324,6200
31 Mar 171,380,066136,230327,9570
31 Dec 161,384,902125,049351,1900
30 Sep 161,351,11795,443367,3610
30 Jun 161,312,923102,804353,4800
31 Mar 161,297,638102,753371,5730
31 Dec 151,225,068188,618324,1140
31 Dec 141,370,46048,840202,8160

Kaliteli Kazançlar: DBD has high quality earnings.

Büyüyen Kar Marjı: DBD's current net profit margins (15%) are higher than last year (14.1%).


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: DBD's earnings have grown by 14.9% per year over the past 5 years.

Büyüme Hızlandırma: DBD's earnings growth over the past year (7.9%) is below its 5-year average (14.9% per year).

Kazançlar vs. Sektör: DBD earnings growth over the past year (7.9%) exceeded the Pharmaceuticals industry -11.5%.


Özkaynak Getirisi

Yüksek ROE: DBD's Return on Equity (16.7%) is considered low.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin